• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-205在食管腺癌中起肿瘤抑制作用,而在食管鳞状细胞癌中起癌基因作用。

MiR-205 functions as a tumor suppressor in adenocarcinoma and an oncogene in squamous cell carcinoma of esophagus.

作者信息

Hezova Renata, Kovarikova Alena, Srovnal Josef, Zemanova Milada, Harustiak Tomas, Ehrmann Jiri, Hajduch Marian, Sachlova Milana, Svoboda Marek, Slaby Ondrej

机构信息

Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic.

Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic.

出版信息

Tumour Biol. 2016 Jun;37(6):8007-18. doi: 10.1007/s13277-015-4656-8. Epub 2015 Dec 28.

DOI:10.1007/s13277-015-4656-8
PMID:26711784
Abstract

Esophageal cancer is a malignant disease with poor prognosis, increasing incidence, and ineffective treatment options. MicroRNAs are post-transcriptional regulators of gene expression involved in many biological processes including carcinogenesis. We determined miR-205 expression levels in tumor/non-tumor tissues of 45 esophageal cancer patients using qPCR and found that decreased level of miR-205 in tumor tissue correlates with poor overall survival in esophageal adenocarcinoma patients. Further, we observed significantly higher levels of miR-205 in tumor tissue of esophageal squamous cell carcinoma. Ectopic overexpression of miR-205 in adenocarcinoma cell line SK-GT-4 led to decreased cell proliferation, cell cycle arrest in G1, and decreased migration ability. Conversely, in squamous cell line KYSE-150, same effects like inhibition of proliferation, migration, and colony-forming potential and cell cycle arrest in G2 were observed after silencing of miR-205. We performed global gene expression profiling and revealed that suppressive functioning of miR-205 in adenocarcinoma could be realized through regulation of epithelial-mesenchymal transition (EMT), whereas oncogenic in squamous cell carcinoma by regulation of metalloproteinase 10. Our results suggest that miR-205 could serve as biomarker in esophageal cancer and acts as a tumor suppressor in esophageal adenocarcinoma and oncogene in esophageal squamous cell carcinoma.

摘要

食管癌是一种预后较差、发病率不断上升且治疗选择无效的恶性疾病。微小RNA是参与包括致癌作用在内的许多生物学过程的基因表达的转录后调节因子。我们使用定量聚合酶链反应(qPCR)测定了45例食管癌患者肿瘤/非肿瘤组织中miR-205的表达水平,发现肿瘤组织中miR-205水平降低与食管腺癌患者的总体生存率较差相关。此外,我们观察到食管鳞状细胞癌肿瘤组织中miR-205水平显著更高。在腺癌细胞系SK-GT-4中异位过表达miR-205导致细胞增殖减少、细胞周期停滞在G1期以及迁移能力下降。相反,在鳞状细胞系KYSE-150中,沉默miR-205后观察到了类似的抑制增殖、迁移和集落形成潜能以及细胞周期停滞在G2期的效果。我们进行了全基因组表达谱分析,发现miR-205在腺癌中的抑制功能可通过调节上皮-间质转化(EMT)来实现,而在鳞状细胞癌中通过调节金属蛋白酶10发挥致癌作用。我们的结果表明,miR-205可作为食管癌的生物标志物,在食管腺癌中起肿瘤抑制作用,在食管鳞状细胞癌中起癌基因作用。

相似文献

1
MiR-205 functions as a tumor suppressor in adenocarcinoma and an oncogene in squamous cell carcinoma of esophagus.微小RNA-205在食管腺癌中起肿瘤抑制作用,而在食管鳞状细胞癌中起癌基因作用。
Tumour Biol. 2016 Jun;37(6):8007-18. doi: 10.1007/s13277-015-4656-8. Epub 2015 Dec 28.
2
MiR-143-3p functions as a tumor suppressor by regulating cell proliferation, invasion and epithelial-mesenchymal transition by targeting QKI-5 in esophageal squamous cell carcinoma.在食管鳞状细胞癌中,miR-143-3p通过靶向QKI-5来调节细胞增殖、侵袭和上皮-间质转化,从而发挥肿瘤抑制作用。
Mol Cancer. 2016 Jun 29;15(1):51. doi: 10.1186/s12943-016-0533-3.
3
Tumor suppressor miR-128-3p inhibits metastasis and epithelial-mesenchymal transition by targeting ZEB1 in esophageal squamous-cell cancer.抑癌 miR-128-3p 通过靶向 ZEB1 抑制食管鳞癌的转移和上皮间质转化。
Acta Biochim Biophys Sin (Shanghai). 2018 Feb 1;50(2):171-180. doi: 10.1093/abbs/gmx132.
4
miR-125b-5p functions as a tumor suppressor gene partially by regulating HMGA2 in esophageal squamous cell carcinoma.miR-125b-5p在食管鳞状细胞癌中部分通过调控HMGA2发挥肿瘤抑制基因的作用。
PLoS One. 2017 Oct 2;12(10):e0185636. doi: 10.1371/journal.pone.0185636. eCollection 2017.
5
miR-143 inhibits tumor progression by targeting FAM83F in esophageal squamous cell carcinoma.在食管鳞状细胞癌中,miR-143通过靶向FAM83F抑制肿瘤进展。
Tumour Biol. 2016 Jul;37(7):9009-22. doi: 10.1007/s13277-015-4760-9. Epub 2016 Jan 13.
6
miR-145-5p Suppresses Tumor Cell Migration, Invasion and Epithelial to Mesenchymal Transition by Regulating the Sp1/NF-κB Signaling Pathway in Esophageal Squamous Cell Carcinoma.miR-145-5p通过调控食管鳞状细胞癌中的Sp1/NF-κB信号通路抑制肿瘤细胞迁移、侵袭及上皮-间质转化
Int J Mol Sci. 2017 Aug 23;18(9):1833. doi: 10.3390/ijms18091833.
7
miR-382 functions as a tumor suppressor against esophageal squamous cell carcinoma.miR-382 作为食管鳞癌细胞的肿瘤抑制因子发挥作用。
World J Gastroenterol. 2017 Jun 21;23(23):4243-4251. doi: 10.3748/wjg.v23.i23.4243.
8
MicroRNA-127 is a tumor suppressor in human esophageal squamous cell carcinoma through the regulation of oncogene FMNL3.微小RNA-127通过调控癌基因FMNL3在人食管鳞状细胞癌中发挥肿瘤抑制作用。
Eur J Pharmacol. 2016 Nov 15;791:603-610. doi: 10.1016/j.ejphar.2016.09.025. Epub 2016 Sep 17.
9
Tumor-suppressive function of miR-139-5p in esophageal squamous cell carcinoma.miR-139-5p在食管鳞状细胞癌中的肿瘤抑制功能
PLoS One. 2013 Oct 18;8(10):e77068. doi: 10.1371/journal.pone.0077068. eCollection 2013.
10
Targeting oncogenic PLCE1 by miR-145 impairs tumor proliferation and metastasis of esophageal squamous cell carcinoma.通过miR-145靶向致癌性PLCE1可损害食管鳞状细胞癌的肿瘤增殖和转移。
Oncotarget. 2016 Jan 12;7(2):1777-95. doi: 10.18632/oncotarget.6499.

引用本文的文献

1
Overexpression of ATP1B2 promotes cancer cell migration and inhibits apoptosis in patients with esophageal squamous cell carcinoma.ATP1B2的过表达促进食管鳞状细胞癌患者癌细胞的迁移并抑制其凋亡。
Oncol Rep. 2025 Aug;54(2). doi: 10.3892/or.2025.8929. Epub 2025 Jun 20.
2
The interaction between ΔNp63α and TAp63α, mediated by miR-205-5p, inhibits the migration of lung adenocarcinoma cells.由miR-205-5p介导的ΔNp63α与TAp63α之间的相互作用抑制肺腺癌细胞的迁移。
Sci Rep. 2025 Apr 3;15(1):11501. doi: 10.1038/s41598-025-95206-4.
3
miR-205-5p Modulates High Glucose-Induced VEGFA Levels in Diabetic Mice and ARPE-19 Cells.

本文引用的文献

1
miRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma.miRNA-205 是肾细胞癌中靶向 ZEB2 的候选肿瘤抑制因子。
Oncol Res Treat. 2014;37(11):658-64. doi: 10.1159/000368792. Epub 2014 Oct 17.
2
Screening miRNAs related to different subtypes of breast cancer with miRNAs microarray.使用miRNA微阵列筛选与乳腺癌不同亚型相关的miRNA。
Eur Rev Med Pharmacol Sci. 2014 Oct;18(19):2783-8.
3
MMP-1 and Pro-MMP-10 as potential urinary pharmacodynamic biomarkers of FGFR3-targeted therapy in patients with bladder cancer.
miR-205-5p调节糖尿病小鼠和ARPE-19细胞中高糖诱导的VEGFA水平。
Antioxidants (Basel). 2025 Feb 14;14(2):218. doi: 10.3390/antiox14020218.
4
Dysregulated LINC01133 expression in laryngeal carcinoma: Prognostic implications and predicted ceRNA interactome.喉癌中LINC01133表达失调:预后意义及预测的ceRNA相互作用组
Mol Biol Res Commun. 2025;14(1):93-107. doi: 10.22099/mbrc.2024.50390.1996.
5
Epigenetic Alterations from Barrett's Esophagus to Esophageal Adenocarcinoma.从巴雷特食管到食管腺癌的表观遗传学改变。
Int J Mol Sci. 2023 Apr 25;24(9):7817. doi: 10.3390/ijms24097817.
6
Survival estimation in patients with stomach and esophageal carcinoma using miRNA expression profiles.利用miRNA表达谱对胃癌和食管癌患者进行生存估计。
Comput Struct Biotechnol J. 2022 Aug 13;20:4490-4500. doi: 10.1016/j.csbj.2022.08.025. eCollection 2022.
7
Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs.头颈部癌症中有前景的生物标志物:最具临床意义的 miRNAs。
Int J Mol Sci. 2022 Jul 26;23(15):8257. doi: 10.3390/ijms23158257.
8
Identification and validation of diagnostic and prognostic biomarkers for lung squamous cell carcinoma.肺鳞状细胞癌诊断和预后生物标志物的鉴定与验证
J Thorac Dis. 2022 Apr;14(4):1243-1255. doi: 10.21037/jtd-22-343.
9
Reverses MDR-1 Mediated Doxorubicin Resistance via in Human Liver Cancer HepG2 Cells.通过逆转人肝癌HepG2细胞中MDR-1介导的阿霉素耐药性。
Cell J. 2022 Mar;24(3):112-119. doi: 10.22074/cellj.2022.7231.
10
The Role of Cancer Stem Cells in Drug Resistance in Gastroesophageal Junction Adenocarcinoma.癌症干细胞在胃食管交界腺癌耐药中的作用
Front Mol Biosci. 2021 Feb 8;8:600373. doi: 10.3389/fmolb.2021.600373. eCollection 2021.
MMP-1 和 Pro-MMP-10 可作为膀胱癌患者 FGFR3 靶向治疗的潜在尿药代动力学生物标志物。
Clin Cancer Res. 2014 Dec 15;20(24):6324-35. doi: 10.1158/1078-0432.CCR-13-3336. Epub 2014 Oct 17.
4
miR-205 and miR-200c: Predictive Micro RNAs for Lymph Node Metastasis in Triple Negative Breast Cancer.miR-205 和 miR-200c:三阴性乳腺癌淋巴结转移的预测性微小 RNA。
J Breast Cancer. 2014 Jun;17(2):143-8. doi: 10.4048/jbc.2014.17.2.143. Epub 2014 Jun 27.
5
ID2 predicts poor prognosis in breast cancer, especially in triple-negative breast cancer, and inhibits E-cadherin expression.ID2 预测乳腺癌预后不良,尤其是三阴性乳腺癌,并抑制 E-钙黏蛋白表达。
Onco Targets Ther. 2014 Jun 18;7:1083-94. doi: 10.2147/OTT.S64759. eCollection 2014.
6
MicroRNA-205 signaling regulates mammary stem cell fate and tumorigenesis.微小RNA-205信号传导调节乳腺干细胞命运和肿瘤发生。
J Clin Invest. 2014 Jul;124(7):3093-106. doi: 10.1172/JCI73351. Epub 2014 Jun 9.
7
Insights into the diverse roles of miR-205 in human cancers.对miR-205在人类癌症中多种作用的见解。
Asian Pac J Cancer Prev. 2014;15(2):577-83. doi: 10.7314/apjcp.2014.15.2.577.
8
MicroRNA-205 suppresses proliferation and promotes apoptosis in laryngeal squamous cell carcinoma.微小 RNA-205 抑制喉鳞状细胞癌的增殖并促进其凋亡。
Med Oncol. 2014 Jan;31(1):785. doi: 10.1007/s12032-013-0785-3. Epub 2013 Dec 3.
9
Prognostic significance of metastasis-related microRNAs in early breast cancer patients with a long follow-up.早期乳腺癌患者长期随访中转移相关 microRNAs 的预后意义。
Clin Chem. 2014 Jan;60(1):197-205. doi: 10.1373/clinchem.2013.210542. Epub 2013 Oct 16.
10
miRNA-205 affects infiltration and metastasis of breast cancer.miRNA-205 影响乳腺癌的浸润和转移。
Biochem Biophys Res Commun. 2013 Nov 8;441(1):139-43. doi: 10.1016/j.bbrc.2013.10.025. Epub 2013 Oct 12.